Combination Therapy For Treating Or Preventing An Inflammatory Skin Disorder

Abstract

Methods and compositions for improved treatment and prevention of an inflammatory skin disorder or a sign and/or symptom associated with the skin disorder are described. The methods involve topical application to the skin a combination of a therapeutically effective amount of an a2 adrenergic receptor agonist, such as brimonidine, and a therapeutically effective amount of a non-steroidal anti-inflammatory agent, such as diclofenac.


Claims
Download PDF
Document Preview
Document History
  • Publication: May 26, 2011
  • Application: Nov 18, 2010
    WO EP 2010067749 W
  • Priority: Nov 18, 2009
    EP EP 09176392 A

Sign in to the Lens